Europe In-Vitro Diagnostics Market will be US$ 32.93 Billion by 2032
Europe In-Vitro Diagnostics Market was US$ 22.40 Billion in 2023 and will grow US$ 32.93 Billion by 2032, with a CAGR of 4.37% from 2024 to 2032. The increasing incidence of infectious diseases, the growing need for point-of-care (PoC) and rapid diagnostics, the growing awareness of early disease diagnosis, the rising cost of healthcare, and the increasing funding for research activities are all factors contributing to the growth of the IVD market in Europe.